| No. 24A871 | |
| Title: | Vanda Pharmaceuticals, Inc., Applicant v. Food and Drug Administration, et al. |
| Docketed: | March 12, 2025 |
| Lower Ct: | United States Court of Appeals for the District of Columbia Circuit |
| Case Numbers: | (23-5200) |
| Date | Proceedings and Orders |
| Mar 07 2025 | Application (24A871) to extend the time to file a petition for a writ of certiorari from March 17, 2025 to May 16, 2025, submitted to The Chief Justice. |
| Main DocumentLower Court Orders/OpinionsLower Court Orders/OpinionsProof of ServiceOther | |
| Mar 12 2025 | Application (24A871) granted by The Chief Justice extending the time to file until May 16, 2025. |
| NAME | ADDRESS | PHONE |
| Attorneys for Petitioner | ||
| Paul Whitfield Hughes Counsel of Record | McDermott Will & Emery 500 North Capitol Street NW Washington, DC 20001 phughes@mwe.com | (202) 756-8981 |
| Party name: Vanda Pharmaceuticals Inc. | ||
| Attorneys for Respondents | ||
| Sarah M. Harris Counsel of Record | Acting Solicitor General United States Department of Justice 950 Pennsylvania Avenue, NW Washington, DC 20530-0001 SUPREMECTBRIEFS@USDOJ.GOV | 202-514-2217 |
| Party name: Food and Drug Administration, et al. | ||